Primary |
Product Used For Unknown Indication |
46.8% |
Drug Use For Unknown Indication |
25.3% |
Anxiety |
9.0% |
Depression |
5.1% |
Panic Attack |
2.0% |
Panic Disorder |
1.6% |
Insomnia |
1.5% |
Hypertension |
1.2% |
Pain |
1.0% |
Intentional Overdose |
0.8% |
Sleep Disorder |
0.7% |
Suicide Attempt |
0.7% |
Anxiety Disorder |
0.7% |
Ill-defined Disorder |
0.7% |
Bipolar Disorder |
0.6% |
Overdose |
0.5% |
Schizophrenia |
0.5% |
Intentional Self-injury |
0.5% |
Major Depression |
0.5% |
Blood Cholesterol Increased |
0.4% |
|
Respiratory Arrest |
20.0% |
Drug Abuse |
13.6% |
Completed Suicide |
12.9% |
Poisoning |
10.1% |
Toxicity To Various Agents |
7.8% |
Death |
5.6% |
Accidental Overdose |
5.4% |
Drug Ineffective |
3.9% |
Suicide Attempt |
3.0% |
Cardio-respiratory Arrest |
2.8% |
Cardiac Arrest |
2.7% |
Intentional Drug Misuse |
2.5% |
Drug Toxicity |
1.7% |
Sopor |
1.6% |
Somnolence |
1.5% |
Tremor |
1.2% |
Overdose |
1.1% |
Product Substitution Issue |
1.0% |
Unresponsive To Stimuli |
0.9% |
Withdrawal Syndrome |
0.8% |
|
Secondary |
Product Used For Unknown Indication |
40.8% |
Drug Use For Unknown Indication |
24.2% |
Anxiety |
8.2% |
Depression |
5.2% |
Pain |
2.8% |
Suicide Attempt |
2.4% |
Insomnia |
2.2% |
Hypertension |
2.0% |
Panic Disorder |
2.0% |
Panic Attack |
1.9% |
Drug Abuse |
1.3% |
Ill-defined Disorder |
1.0% |
Intentional Overdose |
0.9% |
Sleep Disorder |
0.9% |
Psychotic Disorder |
0.9% |
Schizophrenia |
0.8% |
Back Pain |
0.7% |
Anxiety Disorder |
0.6% |
Completed Suicide |
0.6% |
Bipolar Disorder |
0.6% |
|
Completed Suicide |
21.0% |
Respiratory Arrest |
11.0% |
Toxicity To Various Agents |
10.9% |
Drug Abuse |
9.5% |
Cardio-respiratory Arrest |
6.4% |
Death |
5.8% |
Intentional Drug Misuse |
5.1% |
Drug Toxicity |
4.0% |
Poisoning |
4.0% |
Drug Ineffective |
2.6% |
Somnolence |
2.6% |
Cardiac Arrest |
2.3% |
Overdose |
2.2% |
Tremor |
2.1% |
Withdrawal Syndrome |
2.1% |
Suicide Attempt |
2.0% |
Substance Abuse |
1.7% |
Weight Decreased |
1.7% |
Vomiting |
1.6% |
Unresponsive To Stimuli |
1.4% |
|
Concomitant |
Product Used For Unknown Indication |
27.7% |
Drug Use For Unknown Indication |
17.4% |
Anxiety |
8.6% |
Depression |
7.8% |
Hypertension |
6.6% |
Pain |
5.8% |
Rheumatoid Arthritis |
3.6% |
Insomnia |
3.1% |
Gastrooesophageal Reflux Disease |
2.3% |
Diabetes Mellitus |
2.1% |
Prophylaxis |
2.0% |
Sleep Disorder |
1.7% |
Asthma |
1.6% |
Osteoporosis |
1.6% |
Chronic Obstructive Pulmonary Disease |
1.4% |
Crohn's Disease |
1.4% |
Blood Cholesterol Increased |
1.4% |
Bipolar Disorder |
1.4% |
Multiple Sclerosis |
1.3% |
Breast Cancer |
1.3% |
|
Vomiting |
14.2% |
Weight Decreased |
10.4% |
Weight Increased |
9.7% |
Nausea |
5.5% |
Pain |
5.0% |
Tremor |
4.9% |
Death |
4.6% |
Drug Ineffective |
4.2% |
Urinary Tract Infection |
4.2% |
Pulmonary Embolism |
4.1% |
Type 2 Diabetes Mellitus |
4.0% |
Pneumonia |
3.9% |
Somnolence |
3.7% |
Wrong Technique In Drug Usage Process |
3.6% |
Pain In Extremity |
3.2% |
Vision Blurred |
3.2% |
Pyrexia |
3.1% |
Myocardial Infarction |
3.0% |
Rash |
3.0% |
Suicidal Ideation |
2.7% |
|
Interacting |
Product Used For Unknown Indication |
24.8% |
Anxiety |
13.8% |
Drug Use For Unknown Indication |
10.5% |
Depression |
9.4% |
Hypertension |
5.8% |
Pain |
5.8% |
Insomnia |
4.2% |
Smoking Cessation Therapy |
4.0% |
Gastrooesophageal Reflux Disease |
3.3% |
Gastritis |
2.7% |
Asthma |
2.0% |
Epilepsy |
1.8% |
Hypersensitivity |
1.8% |
Vitamin Supplementation |
1.8% |
Hiatus Hernia |
1.6% |
Fatigue |
1.3% |
Multiple Sclerosis Relapse |
1.3% |
Neuralgia |
1.3% |
Panic Disorder |
1.3% |
Sinus Disorder |
1.3% |
|
Drug Interaction |
18.8% |
Somnolence |
8.7% |
Depression |
7.2% |
Suicidal Ideation |
7.2% |
Toxicity To Various Agents |
7.2% |
Tremor |
5.8% |
Overdose |
4.3% |
Syncope |
4.3% |
Vomiting |
4.3% |
Aggression |
2.9% |
Appendicitis |
2.9% |
Asthenia |
2.9% |
Bronchopneumonia |
2.9% |
Confusional State |
2.9% |
Coordination Abnormal |
2.9% |
Dysgeusia |
2.9% |
Hepatitis C |
2.9% |
Loss Of Consciousness |
2.9% |
Memory Impairment |
2.9% |
Multiple Drug Overdose |
2.9% |
|